Clinical Trial Update: A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing aripiprazole to other atypical antipsychotics in schizophrenic patients with metabolic syndrome was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Metabolic Syndrome, Schizophrenia | Phase 4 | Status: TERMINATED | Results posted: 2010-07-20